Disruption of oncogene/tumor suppressor networks during human carcinogenesis

Cancer Investigation

Volumn 20, Issue 1, 2002, Pages 71-81

  Münger, Karl ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; PROTEIN;

CANCER; CANCER RESEARCH; CARCINOGENESIS; CONFERENCE PAPER; GENE ACTIVATION; GENE AMPLIFICATION; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENE FUSION; GENE MUTATION; GENE TRANSFER; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STABILITY; PROTO ONCOGENE; RETROVIRUS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS ONCOGENE;

ANIMALS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS; ONCOGENES; SIGNAL TRANSDUCTION;

EID: 0036169417     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120000369     Document Type: Conference Paper

References (117)

1. Cell transformation by viruses
2. Induction of apoptosis in fibroblasts by c-myc protein
3. INK4a
4. The age distribution of cancer and a multi-stage theory of carcinogenesis
5. Cutaneous chemical carcinogenesis: Past, present, and future
6. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
7. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
8. Creation of human tumor cells with defined genetic elements
9. The multistep nature of cancer
10. Genetic alterations during colorectal-tumor development
11. Genomics: Journey to the center of biology
12. A gene expression database for the molecular pharmacology of cancer
13. Chromosomal deletion and retinoblastoma
14. Mutation and cancer: Statistical study of retinoblastoma
15. Tumor suppressor and overgrowth suppressor genes of Drosophila Melanogaster: Developmental aspects
16. What is drosophila telling us about cancer?
17. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
18. Association of adenovirus early region 1A proteins with cellular polypeptides
19. Detection of cellular proteins associated with human adenovirus type 5 early region E1A polypeptides
20. Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses
21. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
22. Polyoma virus transforming protein associates with the product of the c-src cellular gene
23. T antigen is bound to a host protein in SV40-transformed cells
24. Characterization of a 54k Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
25. Adenovirus E1b-58kD tumor antigen and SV40 large tumor antigen are physically associated with the same 54kD cellular protein in transformed cells
26. Association between an oncogene and an antioncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
27. The cat and mouse games that genes, viruses, and cells play
28. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
29. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
30. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to adenovirus E1a
31. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product
32. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product
33. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
34. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element
35. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase
36. Evolving ideas about cyclins
37. Cancer cell cycles
38. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
39. The retinoblastoma protein and cell cycle control
40. Retinoblastoma protein switches the E2F site from positive to negative element
41. The regulation of E2F by pRB-family proteins
42. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumors
43. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
44. D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer
45. Amplification and expression of the human cyclin D gene in esophageal cancer
46. Cyclin D1 (PRAD1) protein expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene
47. Cyclin-Dependent Kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA
48. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines
49. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2
50. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas
51. p16 proteins from melanomaprone families are deficient in binding to Cdk4
52. Germline p16 mutations in familial melanoma
53. Analysis of the p16 Gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
54. Candidate tumor-suppressor genes MTS1 (p16(INK4A)) and MTS2 (p15(INK4B)) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias
55. E2F and cell proliferation: A world turned upside down
56. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
57. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
58. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma
59. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer
60. Association of human papillomavirus types 16 and 18 E6 proteins with p53
61. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse
62. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
63. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by friend leukemia virus
64. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
65. The p53 protooncogene can act as a suppressor of transformation
66. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
67. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome
68. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasias
69. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control
70. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
71. Cancer: p53, guardian of the genome
72. DNA damage activates p53 through a phosphorylation-acetylation cascade
73. WAF1, a potential mediator of p53 tumor suppression
74. The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases
75. pRB plays an essential role in cell cycle arrest induced by dna damage
76. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1
77. A model for p53-induced apoptosis
78. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
79. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
80. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family
81. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
82. Regulation of p53 stability by Mdm2
83. Mdm2 promotes the rapid degradation of p53
84. Mdm2 expression is induced by wild type p53 activity
85. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
86. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
87. MDM2 gene amplification in metastatic osteosarcoma
88. p53 mutation and MDM2 amplification in human soft tissue sarcomas
89. Interaction between the retinoblastoma protein and the oncoprotein MDM2
90. RB regulates the stability and the apoptotic function of p53 via MDM2
91. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
92. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
93. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
94. p14ARF links the tumour suppressors RB and p53
95. The ARF/p53 pathway
96. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
97. Interaction of D-type cyclins with a novel Myb-like transcription factor, DMP1
98. The p16INK4a/CDKN2A tumor suppressor and its relatives
99. Cancer, aging and cellular senescence
100. An alternative pathway for yeast telomere maintenance rescues est1-senescence
101. Specific association of human telomerase activity with immortal cells and cancer
102. Myc activates telomerase
103. Direct activation of TERT transcription by c-MYC
104. Risky immortalization by telomerase
105. Telomerase activation by the E6 gene product of human papillomavirus type 16
106. Extension of life-span by introduction of telomerase into normal human cells
107. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
108. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
109. Benefits of bad telomeres
110. Aneuploidy and cancer
111. The clonal evolution of tumor cell populations
112. Altered cell cycle arrest and gene amplification potential accompany loss of wildtype p53
113. Induction of chromosomal abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene
114. The centrosome
115. Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A
116. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle
117. Genetic instability and Darwinian selection in tumours